Diagnostic Lab to Pay $16 Million over Allegations of Billing for Medically Unnecessary Tests
Inform Diagnostics of Boston—formerly known as Miraca Life Sciences, and now owned by Fulgent Genetics—has agreed to a $16 million settlement over allegations it routinely conducted additional tests on biopsy specimens without determining if they were medically necessary, and billed Medicare and other federal programs for those tests.
🔒 Members Only · Compliance & Enforcement BriefYou’ve reached the member portion of this brief.Members read the full analysis and the source documents in every case digest, six days a week.
$750/year